453 related articles for article (PubMed ID: 27890923)
41. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
42. A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation.
Javaid H; Barberis A; Chervova O; Nassiri I; Voloshin V; Sato Y; Ogawa S; Fairfax B; Buffa F; Humphrey TC
BMC Cancer; 2023 Aug; 23(1):721. PubMed ID: 37528416
[TBL] [Abstract][Full Text] [Related]
43. Epigenetics of kidney cancer and bladder cancer.
Hoffman AM; Cairns P
Epigenomics; 2011 Feb; 3(1):19-34. PubMed ID: 22126150
[TBL] [Abstract][Full Text] [Related]
44. Histone Modifying Enzymes in Gynaecological Cancers.
Ramarao-Milne P; Kondrashova O; Barry S; Hooper JD; Lee JS; Waddell N
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669182
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic Regulatory Enzymes: mutation Prevalence and Coexistence in Cancers.
Sharma A; Liu H; Herwig-Carl MC; Chand Dakal T; Schmidt-Wolf IGH
Cancer Invest; 2021 Mar; 39(3):257-273. PubMed ID: 33411587
[TBL] [Abstract][Full Text] [Related]
46. Inactivation of Epigenetic Regulators due to Mutations in Solid Tumors.
Nemtsova MV; Mikhaylenko DS; Kuznetsova EB; Bykov II; Zamyatnin AA
Biochemistry (Mosc); 2020 Jul; 85(7):735-748. PubMed ID: 33040718
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic deregulations in chordoma.
Yu X; Li Z
Cell Prolif; 2015 Oct; 48(5):497-502. PubMed ID: 26256106
[TBL] [Abstract][Full Text] [Related]
48. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Lee JJ; Sholl LM; Lindeman NI; Granter SR; Laga AC; Shivdasani P; Chin G; Luke JJ; Ott PA; Hodi FS; Mihm MC; Lin JY; Werchniak AE; Haynes HA; Bailey N; Liu R; Murphy GF; Lian CG
Clin Epigenetics; 2015; 7(1):59. PubMed ID: 26221190
[TBL] [Abstract][Full Text] [Related]
49. Cancer genetics and epigenetics: two sides of the same coin?
You JS; Jones PA
Cancer Cell; 2012 Jul; 22(1):9-20. PubMed ID: 22789535
[TBL] [Abstract][Full Text] [Related]
50. The epigenetic landscape of clear-cell renal cell carcinoma.
Kluzek K; Bluyssen HA; Wesoly J
J Kidney Cancer VHL; 2015; 2(3):90-104. PubMed ID: 28326264
[TBL] [Abstract][Full Text] [Related]
51. Driver and passenger mutations in cancer.
Pon JR; Marra MA
Annu Rev Pathol; 2015; 10():25-50. PubMed ID: 25340638
[TBL] [Abstract][Full Text] [Related]
52. A global assessment of cancer genomic alterations in epigenetic mechanisms.
Shah MA; Denton EL; Arrowsmith CH; Lupien M; Schapira M
Epigenetics Chromatin; 2014; 7(1):29. PubMed ID: 25484917
[TBL] [Abstract][Full Text] [Related]
53. Methylation-mediated molecular dysregulation in clinical oral malignancy.
Towle R; Garnis C
J Oncol; 2012; 2012():170172. PubMed ID: 22645611
[TBL] [Abstract][Full Text] [Related]
54. Certain subsets of renal neoplasms behave differently, but why?
Holland JM
J Urol; 1996 Jul; 156(1):40. PubMed ID: 8648833
[No Abstract] [Full Text] [Related]
55. Kidney cancer: Bap1 and Pbrm1 determine tumour grade.
Sidaway P
Nat Rev Urol; 2017 Jul; 14(7):391. PubMed ID: 28561809
[No Abstract] [Full Text] [Related]
56. Oncometabolite mechanism unravelled.
Bradley CA
Nat Rev Urol; 2018 Nov; 15(11):656-657. PubMed ID: 30185913
[No Abstract] [Full Text] [Related]
57. Jarid2 binds mono-ubiquitylated H2A lysine 119 to mediate crosstalk between Polycomb complexes PRC1 and PRC2.
Cooper S; Grijzenhout A; Underwood E; Ancelin K; Zhang T; Nesterova TB; Anil-Kirmizitas B; Bassett A; Kooistra SM; Agger K; Helin K; Heard E; Brockdorff N
Nat Commun; 2016 Nov; 7():13661. PubMed ID: 27892467
[TBL] [Abstract][Full Text] [Related]
58. Genetic predisposition to kidney cancer.
Schmidt LS; Linehan WM
Semin Oncol; 2016 Oct; 43(5):566-574. PubMed ID: 27899189
[TBL] [Abstract][Full Text] [Related]
59. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.
Mehdi A; Riazalhosseini Y
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28812986
[TBL] [Abstract][Full Text] [Related]
60. Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.
Owen D; Sheffield BS; Ionescu D; Churg A
Hum Pathol; 2017 Feb; 60():82-85. PubMed ID: 27984124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
